Curis, Inc.
Curis, Inc. (CRIS) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
cris · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Curis, Inc. (CRIS) measures how much investors pay for each dollar of the company's trailing earnings. CRIS's current PE ratio of N/A is calculated by dividing its stock price of $0.47 by its TTM earnings per share of -$0.11.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Curis, Inc.You CRIS | $6M | N/A | — | -$0.11 |
 Aspire Biopharma Holdings, Inc. ASBP | $1M | N/A | — | -$16.38 |
 Athira Pharma, Inc. ATHA | $27M | N/A | — | -$24.70 |
 BriaCell Therapeutics Corp. BCTX | $6M | N/A | — | -$19.37 |
 Citius Pharmaceuticals, Inc. CTXR | $7M | N/A | — | -$3.38 |
 Entero Therapeutics, Inc. ENTO | $14M | N/A | — | -$4.05 |
 Hoth Therapeutics, Inc. HOTH | $18M | N/A | — | -$0.90 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.06 | — | |
2024-12-31 FY2024 | — | $-6.88 | — | |
2023-12-31 FY2023 | — | $-8.96 | — | |
2022-12-31 FY2022 | — | $-12.14 | — | |
2021-12-31 FY2021 | — | $-9.92 | — | |
2020-12-31 FY2020 | — | $-12.29 | — | |
2019-12-31 FY2019 | — | $-19.37 | — | |
2018-12-31 FY2018 | — | $-19.67 | — | |
2017-12-31 FY2017 | — | $-35.75 | — | |
2016-12-31 FY2016 | — | $-45.50 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Curis, Inc. (CRIS) measures how much investors pay for each dollar of the company's trailing earnings. CRIS's current PE ratio of N/A is calculated by dividing its stock price of $0.47 by its TTM earnings per share of -$0.11.
Frequently asked questions
CRIS pe ratio · 6 questionsCRIS's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.47 and TTM EPS of -$0.11. Data sourced from Financial Modeling Prep via CRIS's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Curis, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09